Clinical Trial

White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)

Study acronym: OWN-NPH
Recruiting
View on ClinicalTrials.gov →
Summary
Idiopathic Normal Pressure Hydrocephalus (iNPH) is a progressive condition of the elderly that results in severe disability. iNPH can dramatically respond to Cerebral spinal fluid(CSF)-shunting where excess ventricular fluid is diverted from the brain. Not all patients with iNPH respond to CSF-shunting however. The reasons for this are uncertain. Aim 1: To understand if specific nerve pathways (white matter tracts) that are near ventricles are damaged in patients that respond to shunting as opposed to those that do not. Aim 2: Can we explain shunt non-responsiveness by screening for dementia like illnesses (neurodegeneration) using a large array of methods. Aim 3: To understand whether wearable activity and bed sleep monitors are palatable in a NPH population and to understand if these metrics relate to quality of life. Aim 4: To see whether self-administered digital cognitive assessments can measure improvements pre and post surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-01.
Trial Details
NCT Number NCT07103681
Lead Sponsor Imperial College London
Collaborators: Medical Research Council, Michael J. Fox Foundation for Parkinson's Research, University College, London, University of Edinburgh, King's College London
Conditions Normal Pressure Hydrocephalus
Enrollment 100 participants
Start Date 2025-03-25
Primary Completion 2028-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-27